Cardiovascular risk in patients with coexisting Diabetes mellitus and Hypertension in Bang Chalong Health Promotion Hospital, Bang Phli District, Samutprakan Province


  • Nopphanath Chumpathat Faculty of Nursing, Huachiew Chalermprakiet University
  • Siriporn Chunchai Nursing Department, Rajavithi Hospital
  • Sivaporn Wannaiampikul Department of Biochemistry, Faculty of Medicine, Srinakharinwirot University
  • Prisana Akaratanapol Faculty of Nursing, Huachiew Chalermprakiet University
  • Siriwan Turongruang Faculty of Nursing, Huachiew Chalermprakiet University
  • Rachada Phuangprasonka Faculty of Nursing, Huachiew Chalermprakiet University
  • Brian Lee Department of Medicine, Faculty of Medicine, Srinakharinwirot University


Cardiovascular risk, coexisting diabetes mellitus and hypertension, Thai CV risk score


Diabetes mellitus and hypertension frequently occur together, which greatly increases the risk of cardiovascular disease. Diabetic patients with hypertension often have dyslipidemia and a waist circumference exceeding the norm. These abnormalities are components of a metabolic syndrome. The objectives of this study were to explore cardiovascular risk levels and associated factors in patients with concurrent Diabetes mellitus and hypertension without prior cardiovascular disease. The collected data from subjects who attended their annual health check-up at Bang Chalong Subdistrict Health Promotion Hospital, Bang Phli District in Samutprakarn Province. The cardiovascular risk level was determined by the Thai CV Risk Score. The results found that there were 190 eligible patients, 127 patients were females (66.8%), and 65.8% of all patients were aged 60 years old or over. The male patients who smoked had low levels of high-density lipoprotein cholesterol at a significantly higher proportion than female patients. Furthermore, 39.4% of patients with coexisting Diabetes mellitus and hypertension had a cardiovascular risk level > 20% or higher, and 79.5% had a metabolic syndrome. In addition, men were found to have a higher level of cardiovascular risk than women (OR=2.23, 95%CI=1.2-4.1, p=0.016), and patients aged 60 years old or over had a higher level of cardiovascular risk than those under 60 years old (OR=12.12, 95%CI=4.9-30.1, p<0.001). In conclusion, this study found more than one third of patients with concurrent diabetes mellitus and hypertension had higher cardiovascular risk levels. In particular, cardiovascular risk was significantly increased among elderly men.


Download data is not yet available.


Tiptaradol S, Aekplakorn W. Prevalence, awareness, treatment and control of coexistence of diabetes and hypertension in Thai population. Int J Hypertens 2012; 2012:386453.

Tsimihodimos V, Gonzalez-Villalpando C, Meigs JB, et al. Hypertension and diabetes mellitus: coprediction and time trajectories. Hypertension 2018;71:422-8.

Sowers JR. Diabetes mellitus and vascular disease. Hypertension 2013;61:943-7.

Petrie JR, Guzik TJ, Touyz RM. Diabetes,hypertension, and cardiovascular disease: Clinical insights and vascular mechanisms. Can J Cardiol 2018;34:575-84.

Lastra G, Syed S, Kurukulasuriya LR, et al. Type 2 diabetes mellitus and hypertension: An update. Endocrinol Metab Clin North Am 2014;43:103-22.

Passarella P, Kiseleva TA, Valeeva FV, et al. Hypertension management in diabetes: 2018 update. Diabetes Spectr 2018;31:218-24.

Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.

World Health Organization. Hypertension care in Thailand: best practices and challenges. [Internet]. 2019. [cited 2020 June 12]. Available from: https://apps. 488/9789290227403-eng.pdf?sequence= 1&isAllowed=y.

Department of Non-Communicable Disease. Guidelines for assessment of cardiovascular risk. 1, editor. Thailand 2018. (in Thai)

Thai CV Risk Score. [Internet]. [cited 2020 June 12]. Available from: https://med. cv_risk_score/tcvrs_en.html. (in Thai)

World Health Organization. [database on internet]. Waist circumference and waist-hip ratio: report of a WHO expert consultation, Geneva, 8-11 December 2008. [cited 2020 June 12]. Available from: 44583.

Ashwell M, Gunn P, Gibson S. Waist-toheight ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev 2012;13:275-86.

Ray K, Sattar N, Bailey C, et al. PACE Special: 5 Things a cardiologist should know about diabetes. [Internet]. [cited 2020 June 12]. Available from: 2018/03/29/pace-special-5-things-acardiologist-should-know-about-diabetes.

Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel

on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.

Vega GL, Barlow CE, Grundy SM, et al. Triglyceride-to-high-density-lipoproteincholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men. J Investig Med 2014;62:345-9.

Wan EYF, Fung CSC, Yu EYT, et al. Effect of multifactorial treatment targets and relative importance of hemoglobin A1c, blood pressure, and low-density lipoprotein-cholesterol on cardiovascular

diseases in Chinese primary care patients with type 2 diabetes mellitus: a populationbased retrospective cohort study. J Am Heart Assoc 2017;6:e006400.

Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract 2016; 22:1-203.

Deepae P, Khungtumneam K, Chumpathat N. Factors related to health promoting behaviors for cardiovascular disease prevention among diabetes with hypertension patients in Muang District, Chachoengsao province. JHNR 2019;35: 46-59. (in Thai)

Zafari N, Asgari S, Lotfaliany M, et al. Impact of hypertension versus diabetes on cardiovascular and all-cause mortality in Iranian older adults: results of 14 years of follow-up. Sci Rep 2017;7:14220.

Sousa AC, Jardim TV, Costa TO, et al. Hypertensive diabetic patients: incidence of cardiovascular and renal outcomes in a historical cohort over 11 years. Diabetol Metab Syndr 2017;9:98.

Momala K, Kongkum P. Factors affecting to stroke prevention behaviors of chronic disease patients at Bankao Health Promoting Hospital, Photharam District, Ratchaburi Province. HCU Journal 2020; 24:172-85. (in Thai)

Norasigha P, Navaphongpaveen K, Piyaaramwong P. Prevalence and associated factors of metabolic syndrome in Buddhist monks at Phra Nakhon Si Ayutthaya Province, Thailand. J Med Health Sci 2018;25:21-9. (in Thai)

Newtonraj A, Selvaraj K, Purty AJ, et al. Feasibility and outcome of communitybased screening for cardiovascular disease risk factors in a remote rural area of South India: The Chunampet rural-cardiovascular health assessment and management program. Indian J Endocrinol Metab 2019;23:628-34.

Punset K, Klinthuesin S, Kingkaew A, et al. Cardiovascular risk among staffs working at the central of Ministry of Public Health using risk assessment of Rama – EGAT Heart Score. NJPH 2015;25:57-70. (in Thai)

King RJ, Grant PJ. Diabetes and cardiovascular disease: pathophysiology of a life-threatening epidemic. Herz 2016; 41:184-92.

Khanam MA, Qiu C, Lindeboom W, et al. The metabolic syndrome: prevalence, associated factors, and impact on survival among older persons in rural Bangladesh. PLoS One 2011;6:e20259.

Zhang H, Qin L, Sheng CS, et al. ASCVD risk stratification modifies the effect of HbA1c on cardiovascular events among patients with type 2 diabetes mellitus with basic to moderate risk. BMJ Open Diabetes Res Care 2020;8:e000810.

Chen YY, Lin YJ, Chong E, et al. The impact of diabetes mellitus and corresponding HbA1c levels on the future risks of cardiovascular disease and mortality: a representative cohort study in Taiwan. PLoS One 2015;10:e0123116.

2016 RCPT Clinical practice guideline on pharmacologic therapy of dyslipidemia for atherosclerotic cardiovascular disease prevention. [Internet]. 2016. [cited 2020 June 12]. Available from: (in Thai)






Original Article (บทความวิจัย)